Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C2828
http://purl.obolibrary.org/obo/NCIT_C2828
|
|---|---|
| Preferred Name | Topotecan Hydrochloride |
| Definitions |
The hydrochloride salt of a semisynthetic derivative of camptothecin with antineoplastic activity. During the S phase of the cell cycle, topotecan selectively stabilizes topoisomerase I-DNA covalent complexes, inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when complexes are encountered by the DNA replication machinery. Camptothecin is a cytotoxic quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | The hydrochloride salt of a semisynthetic derivative of camptothecin with antineoplastic activity. During the S phase of the cell cycle, topotecan selectively stabilizes topoisomerase I-DNA covalent complexes, inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when complexes are encountered by the DNA replication machinery. Camptothecin is a cytotoxic quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. |
|---|---|
| prefLabel | Topotecan Hydrochloride
|
| label | Topotecan Hydrochloride
|
| PDQ_Closed_Trial_Search_ID | 41185
|
| code | C2828
|
| Has_Target | |
| prefixIRI | NCIT:C2828
|
| in_subset |
See more
See less
|
| Display_Name | Topotecan Hydrochloride
|
| Preferred_Name | Topotecan Hydrochloride
|
| FDA_UNII_Code | 956S425ZCY
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | C23H23N3O5.HCl
|
| Maps_To | Topotecan Hydrochloride
|
| CAS_Registry | 119413-54-6
|
| NSC Number | 609699
|
| NCI_Drug_Dictionary_ID | 41185
|
| Legacy Concept Name | Topotecan_Hydrochloride
|
| Has_Free_Acid_Or_Base_Form | |
| type | |
| ALT_DEFINITION | A drug used to treat certain types of ovarian cancer, lung cancer, and cervical cancer. Hycamtin is a type of topoisomerase inhibitor.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 41185
|
| Accepted_Therapeutic_Use_For | Small Cell Lung Carcinoma; Cervical Cancer
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C0886549
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |